[일반원칙] 당뇨병용제
구 분	현 행	개 정(안)	사유
[일반원칙] 당뇨병용제	( 생 략 ) - 아 래 - 가. ∼ 바. ( 생 략 ) ※ 대상약제 [경구제 중 단일제] ( 생 략 ) [경구제 중 복합제] ⋅Glibenclamide+Metformin HCl, Gliclazide+Metformin HCl, Glimepiride+Metformin HCl ⋅Mitiglinide calcium hydrate+Metformin HCl, Nateglinide+ Metformin HCl, Repaglinide+Metformin HCl ⋅Voglibose+Metformin HCl ⋅Lobeglitazone sulfate+Metformin HCl, Pioglitazone HCl+Metformin HCl, Rosiglitazone maleate+ Metformin HCl ⋅Pioglitazone HCl+Glimepiride, Rosiglitazone maleate+ Glimepiride ⋅Alogliptin+Metformin HCl, Anagliptin+Metformin HCl, Evogliptin+ Metformin HCl, Gemigliptin+Metformin HCl, Linagliptin+Metformin HCl, Saxagliptin+Metformin HCl, Sitagliptin phosphate+Metformin HCl, Teneligliptin+ Metformin HCl, Vildagliptin+Metformin HCl ⋅ Alogliptin+Pioglitazone HCl ⋅ Dapagliflozin+Metformin HCl [주사제] ( 생 략 )	( 현행과 같음 ) - 아 래 - 가. ∼ 바. ( 현행과 같음 ) ※ 대상약제 [경구제 중 단일제] ( 현행과 같음 ) [경구제 중 복합제] ⋅Glibenclamide+Metformin HCl, Gliclazide+Metformin HCl, Glimepiride+Metformin HCl ⋅Mitiglinide calcium hydrate+Metformin HCl, Nateglinide+ Metformin HCl, Repaglinide+Metformin HCl ⋅Voglibose+Metformin HCl ⋅Lobeglitazone sulfate+Metformin HCl, Pioglitazone HCl+Metformin HCl, Rosiglitazone maleate+ Metformin HCl ⋅Pioglitazone HCl+Glimepiride, Rosiglitazone maleate+ Glimepiride ⋅Alogliptin+Metformin HCl, Anagliptin+Metformin HCl, Evogliptin+ Metformin HCl, Gemigliptin+Metformin HCl, Linagliptin+Metformin HCl, Saxagliptin+Metformin HCl, Sitagliptin phosphate+Metformin HCl, Teneligliptin+ Metformin HCl, Vildagliptin+Metformin HCl ⋅ Alogliptin+Pioglitazone HCl ⋅ Dapagliflozin+Metformin HCl, Empagliflozin + Metformin HCl [주사제] ( 현행과 같음 )	당뇨병복합제 ‘자디앙듀오정’이 신규등재 예정임에 따라, 성분명을 반영함

<별지 2: 변경>